These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 31060030)

  • 1. Matrix metalloproteinases as possible biomarkers of obstructive sleep apnea severity - A systematic review.
    Franczak A; Bil-Lula I; Sawicki G; Fenton M; Ayas N; Skomro R
    Sleep Med Rev; 2019 Aug; 46():9-16. PubMed ID: 31060030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum matrix metalloproteinase-2 as a predictor of level of hypoxemia and severity of obstructive sleep apnea.
    Franczak A; Skomro R; Sawicka J; Bil-Lula I; Nocon A; Fenton M; Lawson J; Sawicki G
    Sleep Breath; 2021 Jun; 25(2):877-886. PubMed ID: 33006024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sleep apnea syndromes and cardiovascular disease].
    Bounhoure JP; Galinier M; Didier A; Leophonte P
    Bull Acad Natl Med; 2005 Mar; 189(3):445-59; discussion 460-4. PubMed ID: 16149210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications.
    Yamauchi M; Kimura H
    Antioxid Redox Signal; 2008 Apr; 10(4):755-68. PubMed ID: 18177236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease.
    McNicholas WT
    Am J Respir Crit Care Med; 2009 Oct; 180(8):692-700. PubMed ID: 19628778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Metalloproteinase-9 Is a Predictive Factor for Systematic Hypertension and Heart Dysfunction in Patients with Obstructive Sleep Apnea Syndrome.
    Wang S; Li S; Wang B; Liu J; Tang Q
    Biomed Res Int; 2018; 2018():1569701. PubMed ID: 29693002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children.
    Sundaram SS; Halbower AC; Klawitter J; Pan Z; Robbins K; Capocelli KE; Sokol RJ
    J Pediatr; 2018 Jul; 198():67-75.e1. PubMed ID: 29752170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.
    Khayat R; Patt B; Hayes D
    Heart Fail Rev; 2009 Sep; 14(3):143-53. PubMed ID: 18807180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstructive sleep apnoea and cardiovascular consequences: Pathophysiological mechanisms.
    Arnaud C; Bochaton T; Pépin JL; Belaidi E
    Arch Cardiovasc Dis; 2020 May; 113(5):350-358. PubMed ID: 32224049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of endothelial dysfunction in obstructive sleep apnea.
    Atkeson A; Jelic S
    Vasc Health Risk Manag; 2008; 4(6):1327-35. PubMed ID: 19337546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical oxidative stress-related markers in patients with obstructive sleep apnea.
    Volná J; Kemlink D; Kalousová M; Vávrová J; Majerová V; Mestek O; Svarcová J; Sonka K; Zima T
    Med Sci Monit; 2011 Sep; 17(9):CR491-7. PubMed ID: 21873945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructive sleep apnea: role of intermittent hypoxia and inflammation.
    May AM; Mehra R
    Semin Respir Crit Care Med; 2014 Oct; 35(5):531-44. PubMed ID: 25333334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions.
    Pack AI; Gislason T
    Prog Cardiovasc Dis; 2009; 51(5):434-51. PubMed ID: 19249449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between obstructive sleep apnea and endogenous carbon monoxide.
    Azuma M; Murase K; Tachikawa R; Hamada S; Matsumoto T; Minami T; Inouchi M; Tanizawa K; Handa T; Oga T; Mishima M; Chin K
    J Appl Physiol (1985); 2017 Jan; 122(1):104-111. PubMed ID: 27856716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension in obstructive sleep apnea: risk and therapy.
    Das AM; Khayat R
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):619-26. PubMed ID: 19505277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.
    Belaidi E; Morand J; Gras E; Pépin JL; Godin-Ribuot D
    Pharmacol Ther; 2016 Dec; 168():1-11. PubMed ID: 27492897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress--a unifying paradigm in obstructive sleep apnea and comorbidities.
    Lavie L
    Prog Cardiovasc Dis; 2009; 51(4):303-12. PubMed ID: 19110132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstructive Sleep Apnea, Oxidative Stress, and Cardiovascular Disease: Evidence from Human Studies.
    Eisele HJ; Markart P; Schulz R
    Oxid Med Cell Longev; 2015; 2015():608438. PubMed ID: 26167241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of Obstructive Sleep Apnea: Cardiovascular Risk of Obstructive Sleep Apnea and Whether Continuous Positive Airway Pressure Reduces that Risk.
    Khayat R; Pleister A
    Sleep Med Clin; 2016 Sep; 11(3):273-86. PubMed ID: 27542874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases.
    Suzuki YJ; Jain V; Park AM; Day RM
    Free Radic Biol Med; 2006 May; 40(10):1683-92. PubMed ID: 16678006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.